KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Other Non-Current Liabilities (2016 - 2026)

Amgen has reported Other Non-Current Liabilities over the past 18 years, most recently at $2.8 billion for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities rose 25.07% year-over-year to $2.8 billion; the TTM value through Mar 2026 reached $2.8 billion, up 25.07%, while the annual FY2025 figure was $2.4 billion, 1.23% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $2.8 billion at Amgen, up from $2.4 billion in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $6.7 billion in Q1 2022 and troughed at $96.0 million in Q1 2024.
  • A 5-year average of $2.2 billion and a median of $2.2 billion in 2025 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 96.59% in 2023 and later skyrocketed 2202.08% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $270.0 million in 2022, then surged by 1633.33% to $4.7 billion in 2023, then crashed by 49.81% to $2.3 billion in 2024, then grew by 1.23% to $2.4 billion in 2025, then increased by 16.23% to $2.8 billion in 2026.
  • Business Quant data shows Other Non-Current Liabilities for AMGN at $2.8 billion in Q1 2026, $2.4 billion in Q4 2025, and $2.2 billion in Q3 2025.